| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Plasmodium falciparum gametocytemia and its related infectivity for mosquitoes was studied in 115 patients (median age = 18 years, range = 4-45) with simple malaria attacks who lived in the hypoendemic area of Dakar, Senegal. Patients were included in a 28-day in vivo sensitivity test after treatment with chloroquine (CQ, n = 82) or sulfadoxine plus pyrimethamine (SP, n = 33). The prevalence of resistant infections was 58.5% in those treated with CQ and 0% in those treated with SP. The gametocytemia peaked at day 7 after treatment. The maximal gametocyte prevalence was 38.2% in the CQ-sensitive infection group, 89.6% in the CQ-resistant group, and 97.0% in those treated with SP The maximal geometric mean gametocytemia was 2.19/microl in the CQ-sensitive infection group, 29.12/microl in the CQ-resistant group and 85.55/microl in those treated with SP. The period between appearance of the first clinical symptom and treatment was positively related to gametocyte prevalence at days 0 and 2. Experimental infection of wild Anopheles arabiensis using membrane feeders was performed at days 0 and 7, and mosquito infectivity was measured by oocyst detection on the midgut. At day 0, 14.1% of the patients had infected at least 1 mosquito, and at day 7, this value was 38.5%. The mean percentage of infected mosquitoes was 3.2% at day 0 and 12.6% at day 7. At day 7 after treatment with CQ, the relative risk for patients with resistant infections of infecting anophelines was 4.07 higher than in those with sensitive infections. No difference was observed in infectivity for mosquitoes between RI-type resistance and the RII + RIII-type resistance. A sporonticidal effect of SP was observed at day 7 after treatment. These data show that P. falciparum gametocytes and their infectivity for mosquitoes were differentiated according to the drug used, its efficacy, and the duration of symptoms before treatment; they were not dependent on the density of asexual stages. Prompt treatment of malaria cases performed at the beginning of symptoms could limit the spread of resistant parasites.
This article has been cited by other articles:
|
|
 |
|
  F. MENDEZ, A. MUNOZ, and C. V. PLOWE Use of area under the curve to characterize transmission potential after antimalarial treatment. Am J Trop Med Hyg, October 1, 2006; 75(4): 640 - 644. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Gatton and Q. Cheng Plasmodium falciparum infection dynamics and transmission potential following treatment with sulfadoxine-pyrimethamine J. Antimicrob. Chemother., July 1, 2006; 58(1): 47 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. BURNS, J. BAKER, A. M. AULIFF, M. L. GATTON, M. D. EDSTEIN, and Q. CHENG EFFICACY OF SULFADOXINE-PYRIMETHAMINE IN THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA IN EAST TIMOR. Am J Trop Med Hyg, March 1, 2006; 74(3): 361 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. PIYAPHANEE, S. KRUDSOOD, N. TANGPUKDEE, W. THANACHARTWET, U. SILACHAMROON, N. PHOPHAK, C. DUANGDEE, O. HAOHARN, S. FAITHONG, P. WILAIRATANA, et al. Emergence and clearance of gametocytes in uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg, March 1, 2006; 74(3): 432 - 435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. BOUDIN, A. DIOP, A. GAYE, L. GADIAGA, C. GOUAGNA, I. SAFEUKUI, and S. BONNET PLASMODIUM FALCIPARUM TRANSMISSION BLOCKING IMMUNITY IN THREE AREAS WITH PERENNIAL OR SEASONAL ENDEMICITY AND DIFFERENT LEVELS OF TRANSMISSION Am J Trop Med Hyg, December 1, 2005; 73(6): 1090 - 1095. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. HAMEL, T. HOLTZ, C. MKANDALA, N. KAIMILA, N. CHIZANI, P. BLOLAND, J. KUBLIN, P. KAZEMBE, and R. STEKETEE EFFICACY OF TRIMETHOPRIM-SULFAMETHOXAZOLE COMPARED WITH SULFADOXINE-PYRIMETHAMINE PLUS ERYTHROMYCIN FOR THE TREATMENT OF UNCOMPLICATED MALARIA IN CHILDREN WITH INTEGRATED MANAGEMENT OF CHILDHOOD ILLNESS DUAL CLASSIFICATIONS OF MALARIA AND PNEUMONIA Am J Trop Med Hyg, September 1, 2005; 73(3): 609 - 615. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Marks, J. Evans, C. G. Meyer, E. N. Browne, C. Flessner, V. von Kalckreuth, T. A. Eggelte, R. D. Horstmann, and J. May High Prevalence of Markers for Sulfadoxine and Pyrimethamine Resistance in Plasmodium falciparum in the Absence of Drug Pressure in the Ashanti Region of Ghana Antimicrob. Agents Chemother., March 1, 2005; 49(3): 1101 - 1105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Hallett, C. J. Sutherland, N. Alexander, R. Ord, M. Jawara, C. J. Drakeley, M. Pinder, G. Walraven, G. A. T. Targett, and A. Alloueche Combination Therapy Counteracts the Enhanced Transmission of Drug-Resistant Malaria Parasites to Mosquitoes Antimicrob. Agents Chemother., October 1, 2004; 48(10): 3940 - 3943. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. SUTANTO, S. SUPRIYANTO, P. RUCKERT, PURNOMO, J. D. MAGUIRE, and M. J. BANGS COMPARATIVE EFFICACY OF CHLOROQUINE AND SULFADOXINE-PYRIMETHAMINE FOR UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA AND IMPACT ON GAMETOCYTE CARRIAGE RATES IN THE EAST NUSATENGGARA PROVINCE OF INDONESIA Am J Trop Med Hyg, May 1, 2004; 70(5): 467 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. O. Talisuna, P. Bloland, and U. D'Alessandro History, Dynamics, and Public Health Importance of Malaria Parasite Resistance Clin. Microbiol. Rev., January 1, 2004; 17(1): 235 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. K. BASCO MOLECULAR EPIDEMIOLOGY OF MALARIA IN CAMEROON. XVI. LONGITUDINAL SURVEILLANCE OF IN VITRO PYRIMETHAMINE RESISTANCE IN PLASMODIUM FALCIPARUM Am J Trop Med Hyg, August 1, 2003; 69(2): 174 - 178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. GASASIRA, G. DORSEY, B. NZARUBARA, S. G. STAEDKE, A. NASSALI, P. J. ROSENTHAL, and M. R. KAMYA COMPARATIVE EFFICACY OF AMINOQUINOLINE-ANTIFOLATE COMBINATIONS FOR THE TREATMENT OF UNCOMPLICATED FALCIPARUM MALARIA IN KAMPALA, UGANDA Am J Trop Med Hyg, February 1, 2003; 68(2): 127 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Tjitra, S. Suprianto, J. McBroom, B. J. Currie, and N. M. Anstey Persistent ICT Malaria P.f/P.v Panmalarial and HRP2 Antigen Reactivity after Treatment of Plasmodium falciparum Malaria Is Associated with Gametocytemia and Results in False-Positive Diagnoses of Plasmodium vivax in Convalescence J. Clin. Microbiol., March 1, 2001; 39(3): 1025 - 1031. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
